X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs MYLAN (US) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   MYLAN
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
MYLAN
Dec-18
CADILA HEALTHCARE/
MYLAN
5-Yr Chart
Click to enlarge
High Rs5583,323-   
Low Rs3621,829-   
Sales per share (Unadj.) Rs116.31,529.0-  
Earnings per share (Unadj.) Rs17.941.5-  
Cash flow per share (Unadj.) Rs23.1327.8-  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs85.41,654.1-  
Shares outstanding (eoy) m1,023.74514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.7 234.7%   
Avg P/E ratio x25.762.0 41.5%  
P/CF ratio (eoy) x19.97.9 252.9%  
Price / Book Value ratio x5.41.6 345.6%  
Dividend payout %19.60-   
Avg Mkt Cap Rs m470,6641,325,346 35.5%   
No. of employees `00011.835.0 33.8%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.722,476.8 44.8%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.7610.3 253.6%   
INCOME DATA
Net Sales Rs m119,049786,689 15.1%  
Other income Rs m1,1320-   
Total revenues Rs m120,181786,689 15.3%   
Gross profit Rs m28,475203,566 14.0%  
Depreciation Rs m5,388147,299 3.7%   
Interest Rs m91137,837 2.4%   
Profit before tax Rs m23,30818,430 126.5%   
Minority Interest Rs m6280-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,644-2,932 -192.5%   
Profit after tax Rs m18,29221,362 85.6%  
Gross profit margin %23.925.9 92.4%  
Effective tax rate %24.2-15.9 -152.2%   
Net profit margin %15.42.7 565.8%  
BALANCE SHEET DATA
Current assets Rs m82,005439,286 18.7%   
Current liabilities Rs m60,720320,288 19.0%   
Net working cap to sales %17.915.1 118.2%  
Current ratio x1.41.4 98.5%  
Inventory Days Days7384 87.5%  
Debtors Days Days9893 105.3%  
Net fixed assets Rs m83,703152,605 54.8%   
Share capital Rs m1,024419 244.5%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,445851,054 10.3%   
Long term debt Rs m25,551918,560 2.8%   
Total assets Rs m180,6532,282,857 7.9%  
Interest coverage x26.61.5 1,787.7%   
Debt to equity ratio x0.31.1 27.1%  
Sales to assets ratio x0.70.3 191.2%   
Return on assets %10.62.6 409.9%  
Return on equity %20.92.5 833.4%  
Return on capital %22.03.2 691.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,193163,474 5.6%  
From Investments Rs m-9,737-84,498 11.5%  
From Financial Activity Rs m515-76,156 -0.7%  
Net Cashflow Rs m-291,354 -2.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.81 Rs / USD

Compare CADILA HEALTHCARE With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare CADILA HEALTHCARE With: WOCKHARDT  SHASUN PHARMA  NATCO PHARMA  TORRENT PHARMA  ALKEM LABORATORIES  



Today's Market

Sensex Opens on a Strong Note Tracking Global Cues; Metal & Realty Stocks Lead(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1.7% while the Hang Seng is up 2.4%.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

7 Stocks That Will Remain Evergreen in this Era of Technological Disruption(The 5 Minute Wrapup)

Jun 13, 2019

We are living in an era of disruption. Are your stocks well equipped to adapt to changes that disruption will bring along?

The Great Indian NBFC Bubble Has Burst but I Will Still Recommend These Safe NBFCs(The 5 Minute Wrapup)

Jun 11, 2019

One chart that predicted the NBFC crisis back in 2016.

Just One Stock Made Buffett Billions - And Can Make You Crores(Profit Hunter)

Jun 6, 2019

Coca Cola is arguably one of Warren Buffet's best stock picks. But did you know that small investors picked up the stock five decades before Buffet? Read on...

Kenneth Andrade Would Like Our Real Estate Stock Recommendation with Triple Digit Upside(The 5 Minute Wrapup)

Jun 12, 2019

This real estate stock recommended in Smart Money Secrets offers the most favourable upside potential.

Why Modi 2.0 Will Be Great for These 7 Stocks(Profit Hunter)

Jun 10, 2019

The government's focus on Infra, electricity, water for all will be the key factors for Sensex 1,00,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jun 19, 2019 10:27 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS